Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$26.5 - $38.23 $7.45 Million - $10.7 Million
-281,018 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$29.83 - $56.81 $8.38 Million - $16 Million
281,018 New
281,018 $8.88 Million

Others Institutions Holding ZYME

About Zymeworks Inc.


  • Ticker ZYME
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,694,400
  • Market Cap $898M
  • Description
  • Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...
More about ZYME
Track Michael Burry's Portfolio

Track Michael Burry Portfolio

Follow Michael Burry (Scion Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scion Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scion Asset Management, LLC and Michael Burry with notifications on news.